EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations

Osama Shiraz Shah iD, Azadeh Nasrazadani, Julia Foldi iD, Jennifer M Atkinson, Celina G Kleer iD, Priscilla F McAuliffe iD, Tyler J Johnston iD, Wayne Stallaert, Edaise M da Silva iD, Pier Selenica, Higinio Dopeso iD, Fresia Pareja und 7 weitere

Proceedings of the National Academy of Sciences · 30.07.2024 · 121 (31)

DOI: 10.1073/pnas.2322068121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.07.2024. Verfasst von Osama Shiraz Shah und 18 weiteren Autor:innen. Beteiligte Einrichtung: Womens Cancer Research Center at University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center and Magee Women's Research Institute, Pittsburg…. Hauptthemen laut MEDLINE: Carcinoma, Lobular, Carcinoma, Ductal, Breast, Mutation, Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Dynami Foundation, American Society of Clinical Oncology (ASCO), NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mixed invasive ductal and lobular carcinoma (MDLC) is a rare histologic subtype of breast cancer displaying both E-cadherin positive ductal and E-cadherin negative lobular morphologies within the same tumor, posing challenges with regard to anticipated clinical management. It remains unclear whether these distinct morphologies also have distinct biology and risk of recurrence. Our spatially resolved transcriptomic, genomic, and single-cell profiling revealed clinically significant differences between ductal and lobular tumor regions including distinct intrinsic subtype heterogeneity – e.g., MDLC with triple-negative breast cancer (TNBC) or basal ductal and estrogen receptor positive (ER+) luminal lobular regions, distinct enrichment of cell cycle arrest/senescence and oncogenic (ER and MYC ) signatures, genetic and epigenetic CDH1 inactivation in lobular but not ductal regions, and single-cell ductal and lobular subpopulations with unique oncogenic signatures further highlighting intraregional heterogeneity. Altogether, we demonstrated that the intratumoral morphological/histological heterogeneity within MDLC is underpinned by intrinsic subtype and oncogenic heterogeneity which may result in prognostic uncertainty and therapeutic dilemma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, LobularCarcinoma, Ductal, BreastMutationBreast NeoplasmsHumansFemaleCadherinsGene Expression Regulation, NeoplasticBiomarkers, TumorTriple Negative Breast NeoplasmsTranscriptomeGene Expression Profiling

Stichwörter der Autor:innen

breast cancermixed ductal–lobular carcinomasingle cell omicsspatial transcriptomicstumor heterogeneity

Substanzen

CadherinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Womens Cancer Research Center at University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center and Magee Women's Research Institute, Pittsburgh, PA 15213.
  • Integrative Systems Biology Program, University of Pittsburgh School of Medicine, Pittsburgh PA 15260.
  • Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
  • Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15260.
  • Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15260.
  • Department of Pathology and Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109.

ORCID-Profile: Osama Shiraz Shah, Julia Foldi, Celina G Kleer, Priscilla F McAuliffe, Tyler J Johnston, Edaise M da Silva, Higinio Dopeso, Rohit Bhargava, Peter C Lucas, Adrian V Lee, Steffi Oesterreich

Förderung

  • The Dynami Foundation
  • American Society of Clinical Oncology (ASCO)
  • NCI NIH HHS
  • Breast Cancer Research Foundation (BCRF)
  • NIH HHS
  • HHS | NIH | National Cancer Institute

Zitieren

APA

Shah, O. S., Nasrazadani, A., Foldi, J., Atkinson, J. M., Kleer, C. G., McAuliffe, P. F., Johnston, T. J., Stallaert, W., da Silva, E. M., Selenica, P., Dopeso, H., Pareja, F., Mandelker, D., Weigelt, B., Reis-Filho, J. S., Bhargava, R., Lucas, P. C., Lee, A. V., & Oesterreich, S. (2024). Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations. Proceedings of the National Academy of Sciences, 121(31). https://doi.org/10.1073/pnas.2322068121

Vancouver

Shah OS, Nasrazadani A, Foldi J, Atkinson JM, Kleer CG, McAuliffe PF, et al. Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations. Proceedings of the National Academy of Sciences. 2024;121(31). doi:10.1073/pnas.2322068121

BibTeX
@article{Shah2024,
  author = {Shah, Osama Shiraz and Nasrazadani, Azadeh and Foldi, Julia and Atkinson, Jennifer M and Kleer, Celina G and McAuliffe, Priscilla F and Johnston, Tyler J and Stallaert, Wayne and da Silva, Edaise M and Selenica, Pier and Dopeso, Higinio and Pareja, Fresia and Mandelker, Diana and Weigelt, Britta and Reis-Filho, Jorge S and Bhargava, Rohit and Lucas, Peter C and Lee, Adrian V and Oesterreich, Steffi},
  title = {Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {31},
  doi = {10.1073/pnas.2322068121}
}
Kostenlos starten →